Back
Monopar Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
MNPR
Monopar Therapeutics, Inc.
Last Price:
$68.26
Seasonality Move:
10.04%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
Monopar Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.35 | Sell |
| 20-day SMA: | 74.69 | Sell |
| 50-day SMA: | 79.58 | Sell |
| 200-day SMA: | 53.14 | Buy |
| 8-day EMA: | 70.55 | Sell |
| 20-day EMA: | 74.01 | Sell |
| 50-day EMA: | 75.82 | Sell |
| 200-day EMA: | 57.21 | Buy |
Monopar Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.4 | Sell |
| Relative Strength Index (14 RSI): | 38.64 | Sell |
| Chaikin Money Flow: | -309210 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.06 - 84.9) | Sell |
| Bollinger Bands (100): | (47.41 - 89.71) | Buy |
Monopar Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics, Inc. Stock
Is Monopar Therapeutics, Inc. Stock a Buy?
-
Monopar Therapeutics, Inc. share price is 68.77 while MNPR 8-day simple moving average is 69.35, which is a Sell signal.
-
The stock price of MNPR is 68.77 while Monopar Therapeutics, Inc. 20-day SMA is 74.69, which makes it a Sell.
-
Monopar Therapeutics, Inc. 50-day simple moving average is 79.58 while MNPR share price is 68.77, making it a Sell technically.
-
MNPR stock price is 68.77 and Monopar Therapeutics, Inc. 200-day simple moving average is 53.14, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Sell
43
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy or a Sell?
-
Monopar Therapeutics, Inc. stock is rated a SellThe current Monopar Therapeutics, Inc. [MNPR] share price is $68.77. The Score for MNPR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Monopar Therapeutics, Inc. Stock Info
Market Cap:
459.6M
Price in USD:
68.77
Share Volume:
617.8K
Monopar Therapeutics, Inc. 52-Week Range
52-Week High:
105.00
52-Week Low:
21.00
Sell
43
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Monopar Therapeutics, Inc. Share Price Forecast
-
What is the Monopar Therapeutics, Inc. stock price today?The Monopar Therapeutics, Inc. stock price is 68.77 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics, Inc. is overvalued.
Is Monopar Therapeutics, Inc. Stock a Buy?
-
Monopar Therapeutics, Inc. share price is 68.77 while MNPR 8-day exponential moving average is 70.55, which is a Sell signal.
-
The stock price of MNPR is 68.77 while Monopar Therapeutics, Inc. 20-day EMA is 74.01, which makes it a Sell.
-
Monopar Therapeutics, Inc. 50-day exponential moving average is 75.82 while MNPR share price is 68.77, making it a Sell technically.
-
MNPR stock price is 68.77 and Monopar Therapeutics, Inc. 200-day simple moving average is 57.21, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics, Inc.
Is Monopar Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Technical Analysis of Monopar Therapeutics, Inc.
Should I short Monopar Therapeutics, Inc. stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is -3.4, suggesting Monopar Therapeutics, Inc. is a Sell
-
Monopar Therapeutics, Inc. Relative Strength Index (RSI) is 38.64, which suggest Monopar Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Monopar Therapeutics, Inc. is (70.06 - 84.9), which suggest Monopar Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Monopar Therapeutics, Inc. is (47.41 - 89.71), which suggest Monopar Therapeutics, Inc. is a Buy
* Monopar Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.